NEW YORK, Jan. 13, 2017 -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Centene Corp. (“Centene” or the “Company”) (NYSE:CNC) and certain of its officers, and is on behalf of shareholders who purchased or otherwise acquired Centene securities between April 26, 2016, and September 6, 2016, both dates inclusive (the “Class Period”). Such investors are advised to join this case by visiting the firm’s site: http://www.bgandg.com/cnc.
This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).
On March 24, 2016, Centene announced its acquisition of a health care insurance provider, Health Net, Inc. Following the acquisition of Health Net, Centene guaranteed investors that there had been no negative developments in the Health Net medical reserves. On July 26, 2016, the Company said that, “we did increase reserves for medical claims primarily associated with disputed substance abuse treatment center costs. Additionally, we recorded premium deficiency reserves primarily associated with Arizona and the California individual PPO business.” Following this news, Centene stock dropped close to 9%, to close at just $68.87 on July 26, 2016.
The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements about the recent acquisition of Health Net and failed to disclose that material adverse facts about Centene’s business, operations and prospects, including the underperformance of Health Net legacy insurance programs and the need to increase reserves to offset losses caused by these programs. Specifically, the Complaint alleges that Defendants failed to inform investors (1) that some of Health Net’s insurance programs were failing; (2) that Health Net’s insurance plans were producing substantial losses; (3) that the Company had overstated Health Net’s financial predictions; and (4) consequently, Defendants’ statements about Centene’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis.
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: www.bgandg.com/cnc or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Centene you have until January 17, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact: Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Yael Hurwitz 212-697-6484 | [email protected]


TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
Apple Turns 50: From Garage Startup to AI Crossroads
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
First Western Ship Transits Strait of Hormuz Since Iran War Began
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate 



